Zoetis Inc.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattl…
Drug Manufacturers - Specialty & Generic
US, Parsippany [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Zoetis Inc. (ZTS) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Manufacturers—Specialty & Generic Average | - - | - - | - - | 242,545.94 | 41,584.44 | 1,689.59 | 62,283.05 | -467.12 | 0.01 | 45.3529 | 86.89 | 0.4259 | -0.3875 | 0.00 | 0.01 | 2.4270 | - - | ||
| Maximum | - - | - - | - - | 8,626,028.00 | 528,312.00 | 32,061.00 | 1,988,352.00 | 16,134.00 | 0.08 | 2,279.6263 | 3,215.80 | 1.0000 | 1.6542 | 0.13 | 1.46 | 35.1990 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -15,489.00 | -277,041.00 | -30,106.00 | 0.00 | -1,306.5021 | -853.08 | -3.9254 | -42.3731 | -0.31 | -0.90 | 0.0000 | - - | ||
| Neurocrine Biosciences, Inc. NBIX | 125.65 | 0.65 0.52% | 1,181 vs. 1,016 | 12,721.00 | 515.00 | 43.00 | 119.00 | -113.00 | 0.4300 | 81.2772 | 0.0000 | 0.9752 | 0.0842 | 0.0182 | 0.0125 | 2.3303 | 101.00 | ||
| Intra-Cellular Therapies, Inc. ITCI | 85.69 | 0.24 0.28% | 436 vs. 555 | 9,084.00 | 144.00 | -15.00 | -34.00 | -1,632.00 | -0.1600 | -108.4422 | 0.0000 | 0.9317 | -0.1052 | -0.0254 | -0.0204 | 4.5143 | 106.00 | ||
| Catalent, Inc. CTLT | 60.98 | 1.32 2.21% | 4,869 vs. 1,690 | 11,068.00 | 1,074.00 | -101.00 | -62.00 | -804.00 | -0.5500 | -25.4034 | 0.0000 | 0.2132 | -0.0940 | -0.0280 | -0.0102 | 1.5571 | 181.00 | ||
| Viatris Inc. VTRS | 13.37 | 0.24 1.83% | 7,467 vs. 7,669 | 15,958.00 | 3,656.00 | 113.00 | 563.00 | 4,607.00 | 0.0953 | 31.3228 | 0.0100 | 0.4157 | 0.0311 | 0.0057 | 0.0024 | 0.6507 | 1,193.00 | ||
| Haleon plc HLNCF | 4.56 | 0.08 1.79% | 1 vs. 52 | 41,283.00 | 2,919.00 | 423.00 | 0.00 | 0.00 | 0.0460 | 18.0545 | 0.0000 | 0.6297 | 0.1449 | 0.0253 | 0.0000 | 0.0000 | 9,053.00 | ||
| Amphastar Pharmaceuticals, Inc. AMPH | 45.46 | 0.91 2.04% | 394 vs. 349 | 2,185.00 | 171.00 | 43.00 | 46.00 | 452.00 | 0.9000 | 12.1264 | 0.0000 | 0.5080 | 0.2513 | 0.0642 | 0.0274 | 1.6856 | 48.00 | ||
| Zoetis Inc. ZTS | 176.96 | 0.25 0.14% | 1,503 vs. 2,094 | 79,838.00 | 2,190.00 | 599.00 | 455.00 | 10,696.00 | 1.3100 | 31.9262 | 0.0026 | 0.6895 | 0.2735 | 0.1184 | 0.0417 | 1.7119 | 451.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.